diazepam has been researched along with olanzapine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 11 (52.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Chang, TK; Ensom, MH; Kiang, TK | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bojarski, AJ; Bucki, A; Chłoń-Rzepa, G; Jastrzębska-Więsek, M; Kołaczkowski, M; Partyka, A; Satała, G; Wasik, A; Wesołowska, A | 1 |
| Bojarski, AJ; Bucki, A; Kazek, G; Kołaczkowski, M; Partyka, A; Pawłowski, M; Satała, G; Siwek, A; Wesołowska, A; Zagórska, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Handzlik, J; Jankowska, A; Jastrzębska-Więsek, M; Kieć-Kononowicz, K; Kucwaj-Brysz, K; Kurczab, R; Nitek, W; Partyka, A; Satała, G; Siwek, A; Wesołowska, A; Żesławska, E | 1 |
| Bellgrove, MA; Bradshaw, JL; Vance, A | 1 |
| Bowers, L; Callaghan, P; Clark, N; Evers, C | 1 |
| Arya, P; Bennett, J; Gray, R; Jones, M; Lucas, B | 1 |
| Agius, M; Biocina-Martić, S; Dordević, V; Gruber, EN | 1 |
| Dujmović, J; Jakovljević, M; Jevtović, S; Skocić, M | 1 |
| Afonso, P; Gameiro, Z; Saraiva, S | 1 |
| Aguilera, L; García, JM; Iriondo, O; Rodríguez, T; Zaldibar-Gerrikagoitia, J | 1 |
| Baratto, A; Ferri, G; Follador, H; Martino, N; Miola, A; Perini, GI; Scupola, N; Toffanin, T | 1 |
2 review(s) available for diazepam and olanzapine
| Article | Year |
|---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
19 other study(ies) available for diazepam and olanzapine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Antidepressant- and anxiolytic-like activity of 7-phenylpiperazinylalkyl-1,3-dimethyl-purine-2,6-dione derivatives with diversified 5-HT₁A receptor functional profile.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Mice; Purines; Receptor, Serotonin, 5-HT1A; Structure-Activity Relationship | 2015 |
Structure-activity relationships and molecular studies of novel arylpiperazinylalkyl purine-2,4-diones and purine-2,4,8-triones with antidepressant and anxiolytic-like activity.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Binding Sites; Disease Models, Animal; Models, Molecular; Molecular Structure; Piperazine; Piperazines; Purines; Pyrimidinones; Structure-Activity Relationship | 2015 |
Computer-aided insights into receptor-ligand interaction for novel 5-arylhydantoin derivatives as serotonin 5-HT
Topics: Animals; Antidepressive Agents; Behavior, Animal; Computer-Aided Design; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Hydantoins; Male; Mice; Models, Molecular; Molecular Structure; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship | 2018 |
Local-global processing in early-onset schizophrenia: evidence for an impairment in shifting the spatial scale of attention.
Topics: Adolescent; Affect; Antipsychotic Agents; Attention; Benzodiazepines; Clopenthixol; Diazepam; Female; Flupenthixol; Frontal Lobe; Humans; Male; Olanzapine; Parietal Lobe; Perceptual Disorders; Pirenzepine; Reaction Time; Risperidone; Schizophrenia; Space Perception; Time Factors | 2003 |
Comparisons of psychotropic drug prescribing patterns in acute psychiatric wards across Europe.
Topics: Adult; Benzodiazepines; Biperiden; Chlorpromazine; Clozapine; Cyclohexanols; Diazepam; Drug Administration Schedule; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Europe; Female; Humans; Male; Mood Disorders; Olanzapine; Pharmacoepidemiology; Practice Patterns, Physicians'; Psychiatric Department, Hospital; Psychotropic Drugs; Schizophrenia; Time Factors; Venlafaxine Hydrochloride | 2004 |
Pharmacological management of akathisia in combination with psychological interventions by a mental health nurse consultant.
Topics: Akathisia, Drug-Induced; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Diazepam; Drug Monitoring; Drug Prescriptions; Humans; Male; Nurse Clinicians; Nurse's Role; Nursing Assessment; Nursing Evaluation Research; Olanzapine; Outcome Assessment, Health Care; Patient Compliance; Professional Autonomy; Psychiatric Nursing; Psychiatric Status Rating Scales; Psychotherapy, Brief; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index | 2006 |
"My new Alfa Romeo GT is not in the garage any more": Cognitive behavioural therapy of panic disorder with agoraphobia co morbid with psychosis.
Topics: Adult; Agoraphobia; Antipsychotic Agents; Atenolol; Benzodiazepines; Cognitive Behavioral Therapy; Combined Modality Therapy; Desensitization, Psychologic; Diazepam; Hospitalization; Humans; Male; Olanzapine; Panic Disorder; Paroxetine; Psychotic Disorders; Reality Testing; Socialization | 2006 |
Premorbid combat related ptsd in Huntington's disease - Case report.
Topics: Alleles; Antipsychotic Agents; Atrophy; Benzodiazepines; Cerebral Cortex; Chromosomes, Human, Pair 4; Combat Disorders; Combined Modality Therapy; Comorbidity; Diagnosis, Differential; Diazepam; Fatty Acids, Omega-3; Genetic Testing; Humans; Huntington Disease; Magnetic Resonance Imaging; Male; Medulla Oblongata; Middle Aged; Neurologic Examination; Olanzapine; Patient Care Team; Psychotherapy; Risk Factors; Social Environment; Stress Disorders, Post-Traumatic; Trinucleotide Repeats | 2010 |
Schizophrenia presenting with Koro-like symptoms.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Brain; Diazepam; Electroencephalography; Follow-Up Studies; Humans; Koro; Male; Olanzapine; Schizophrenia; Tomography, X-Ray Computed | 2013 |
Anti-NMDA (a-NMDAR) receptor encephalitis related to acute consumption of metamphetamine: Relevance of differential diagnosis.
Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Anticonvulsants; Autoantibodies; Benzodiazepines; Catatonia; Delayed Diagnosis; Diagnosis, Differential; Diagnostic Errors; Diazepam; Electroconvulsive Therapy; Emergencies; Epilepsies, Partial; Hallucinations; Humans; Infectious Encephalitis; Male; Methamphetamine; Olanzapine; Poisoning; Receptors, N-Methyl-D-Aspartate; Status Epilepticus; Young Adult | 2017 |
A Case Report of Neurosyphilis Limbic Encephalitis With Reversible Geschwind Syndrome and Mood Disorder.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Delusions; Diagnosis, Differential; Diazepam; Female; Humans; Limbic Encephalitis; Magnetic Resonance Imaging; Mood Disorders; Neurosyphilis; Olanzapine; Paranoid Disorders | 2019 |